查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球转型生长因子市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按等级、按应用、按最终用户、按地区
市场调查报告书
商品编码
1389785

全球转型生长因子市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按等级、按应用、按最终用户、按地区

Transforming Growth Factor Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 345 Pages | 商品交期: 2-5个工作天内

价格
简介目录

预计2024年全球转化生长因子（TGF）市场规模将达3.9亿美元，到2031年底预计将达到近7.4亿美元。

虽然 TGF 市场上的许多公司提供各种产品和服务，但人们越来越关注成为 GMP 级产品和试剂的供应商。 这种专门的方法可确保更高的产品品质和成熟的分销网络。 生命科学产业是全球研发支出水准最高的产业之一，且投资预计将持续成长。 此外，研发和技术投资从北美和欧洲转向亚太地区，特别是印度等拥有熟练劳动力和政府激励措施的国家，预计也将推动市场成长。

开发新颖、高成本的产品来满足生命科学研究人员日益复杂的需求正在引起消费者的犹豫，尤其是预算有限的研究团队。 此外，某些生长因子价格昂贵，限制了许多实验室的可用性。 研发部门缺乏熟练的专业人员是另一个挑战，主要是由于工资水平低、任务要求高和培训不足。 缺乏经验丰富的人员以及研究设施的限制可能会阻碍全球市场的成长。

2022年美国市场约占北美市场的94.1%。 美国药品製造资本投资的增加和老牌製造商数量的增加正在推动市场销售。 个人化药物的商业化和新生物製剂研发的增加预计将进一步推动该国市场的发展。

2022年德国在欧洲市场的市占率约为28.2%。 全球人均医疗保健费用的上升对医疗保健支出产生了重大影响。 我们在德国拥有生长因子产品的生产设施，并提高了产品的可用性。 此外，领先公司正在进行併购以扩大其产品组合，从而促进市场成长。

中国在东亚市场占据主导地位，2022 年市占率约 46.8%。 中国经济的成长，加上CRO（合约药物开发组织）和CMO（合约製造组织）的快速成长，正在推动市场销售。 经济、社会和环境的变化正在促进这些发展，减少国家成长结构的不平衡。

本报告调查了全球转化生长因子市场，并提供了市场概述，以及按产品、等级、应用、最终用户、区域以及进入市场的公司的竞争趋势划分的趋势。我们提供

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第 3 章 2018-2031 年全球转化生长因子市场展望

  • 2018-2031 年全球转化生长因子市场前景（按产品）、价值（百万美元）、数量（百万单位）
  • 2018-2031 年全球转化生长因子市场前景（按等级、价值（百万美元）、数量（百万单位））
  • 2018-2031 年全球转化生长因子市场展望，按应用、价值（百万美元）、数量（百万单位）
  • 2018-2031 年全球转换生长因子市场前景（按最终用户划分）、价值（百万美元）、销售量（百万单位）
  • 2018-2031 年全球转换生长因子市场前景（按地区、价值（百万美元）、数量（百万单位））

第 4 章北美转化生长因子市场展望，2018-2031 年

第 5 章欧洲转化生长因子市场展望，2018-2031

第 6 章亚太地区转化生长因子市场展望，2018-2031 年

第 7 章拉丁美洲转型生长因子市场展望，2018-2031 年

第 8 章中东与非洲转型成长因素市场展望，2018-2031 年

第九章竞争态势

  • 依用途和等级划分的热图
  • 按製造商和等级划分的热图
  • 2023 年公司市占率分析
  • 竞争力仪表板
  • 公司简介
    • Thermo Fisher Scientific
    • Lonza Group AG
    • Merck KGaA
    • F. Hoffmann-La Roche Ltd
    • Abcam plc.
    • Bio-Techne.
    • Sartorius CellGenix GmbH
    • Proteintech Group, Inc.
    • PeproTech Inc.
    • Cell Signaling Technology, Inc.
    • Meridian Bioscience Inc.
    • Applied Biological Materials (abm), Inc.
    • Akron Biotech
    • Leadgene Biomedical, Inc
    • GE Healthcare

第 10 章附录

简介目录

Fairfield Market Research, a premier market research firm, has unveiled its latest report on the Transforming Growth Factor (TGF) market, projecting a robust growth trajectory. The global revenue for TGF market was recorded at US$ 390 million in 2024, and it is poised to reach valuation of nearly US$ 740 million by the end of 2031.

Fueling Global TGF Market Growth

Specialty Products and Asia Pacific Market Expansion: While many businesses in the TGF market offer a range of products and services, there is a growing focus on being a supplier of GMP-grade products and reagents. This specialized approach ensures higher product quality and a well-established distribution network. The life sciences industry, which boasts one of the highest R&D spending levels globally, is expected to continue increasing its investment. Furthermore, the shift in R&D and technology investments from North America and Europe to Asia Pacific, particularly in countries like India, with its skilled labor force and government incentives, is expected to drive market growth.

Potential Challenges

Lack of Skilled Professionals and High Product Costs: The development of novel, high-cost products to meet the increasingly complex requirements of life sciences researchers has created hesitation among consumers, particularly research teams with budget constraints. Additionally, certain growth factors come with a hefty price tag, limiting access for many laboratories. A shortage of skilled professionals in the research and development sector, primarily due to low pay scales, demanding duties, and insufficient training, poses another challenge. This shortage of experienced individuals, along with limitations in research facilities, may hamper global market growth.

Country-wise Insights

Booming U.S. Market: The U.S. market accounted for approximately 94.1% of the North America market in 2022. Increasing capital expenditure on pharmaceutical manufacturing and a growing number of established manufacturers within the U.S. have driven market sales. The commercialization of personalized pharmaceutical products and intensified research and development efforts in novel biologics are expected to further boost the market in the country.

Lucrative German Market: Germany held about 28.2% market share in the Europe market in 2022. The rising cost of healthcare per capita globally has significantly affected healthcare spending. The presence of production facilities for growth factor products in Germany has improved product availability. Moreover, major companies are engaging in mergers and acquisitions to expand their product portfolios, contributing to market growth.

Emerging Chinese Market: China dominated the East Asia market with a market share of approximately 46.8% in 2022. China's growing economy, coupled with a surge in Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) activities, has propelled market sales. Economic, social, and environmental shifts have contributed to these developments, reducing imbalances in the country's growth structure.

Competitive Landscape

Market players are employing strategies such as acquisitions, mergers, expansions, and product launches to enhance their market presence. Asia Pacific is witnessing significant Research and Development (R&D) investments by corporations aiming to diversify their product offerings and capture market share in emerging economies.

Key Market Players

  • Thermo Fisher Scientific
  • Lonza Group AG
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd
  • Abcam plc.
  • Bio-Techne.
  • Sartorius CellGenix GmbH
  • Proteintech Group, Inc.
  • PeproTech Inc.
  • Cell Signaling Technology, Inc.
  • Meridian Bioscience Inc.
  • Applied Biological Materials (abm), Inc.
  • Akron Biotech
  • Leadgene Biomedical, Inc
  • GE Healthcare

Key Segments Covered in Transforming Growth Factor Industry Research

Product:

  • Activin
  • Bone Morphogenetic Proteins (BMPs)
  • TGF-beta Proteins

Grade:

  • GMP Grade
  • Non-GMP Grade

Application:

  • Oncology Research
  • Hematology Research
  • Wound Healing Research
  • Dermatology Research
  • Cardiovascular Disease & Diabetes
  • Cell Therapy and Ex vivo Manufacturing
  • Others

End User:

  • Pharmaceutical and Biotechnology Companies
  • Research Centers & Academic Institutes
  • CMO and CDMO

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Transforming Growth Factor Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Transforming Growth Factor Market Outlook, 2018 - 2031

  • 3.1. Global Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Activin
      • 3.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 3.1.1.3. TGF-beta Proteins
  • 3.2. Global Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. GMP Grade
      • 3.2.1.2. Non-GMP Grade
  • 3.3. Global Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Oncology Research
      • 3.3.1.2. Hematology Research
      • 3.3.1.3. Wound Healing Research
      • 3.3.1.4. Dermatology Research
      • 3.3.1.5. Cardiovascular Disease & Diabetes
      • 3.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 3.3.1.7. Others
  • 3.4. Global Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Pharmaceutical and Biotechnology Companies
      • 3.4.1.2. Research Centers & Academic Institutes
      • 3.4.1.3. CMO and CDMO
  • 3.5. Global Transforming Growth Factor Market Outlook, by Region, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Transforming Growth Factor Market Outlook, 2018 - 2031

  • 4.1. North America Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Activin
      • 4.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 4.1.1.3. TGF-beta Proteins
  • 4.2. North America Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. GMP Grade
      • 4.2.1.2. Non-GMP Grade
  • 4.3. North America Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oncology Research
      • 4.3.1.2. Hematology Research
      • 4.3.1.3. Wound Healing Research
      • 4.3.1.4. Dermatology Research
      • 4.3.1.5. Cardiovascular Disease & Diabetes
      • 4.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 4.3.1.7. Others
  • 4.4. North America Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Pharmaceutical and Biotechnology Companies
      • 4.4.1.2. Research Centers & Academic Institutes
      • 4.4.1.3. CMO and CDMO
  • 4.5. North America Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.2. U.S. Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.3. U.S. Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031 by End User
      • 4.5.1.4. U.S. Transforming Growth Factor Market, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.5. Canada Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.6. Canada Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.7. Canada Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 4.5.1.8. Canada Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Transforming Growth Factor Market Outlook, 2018 - 2031

  • 5.1. Europe Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Activin
      • 5.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 5.1.1.3. TGF-beta Proteins
  • 5.2. Europe Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. GMP Grade
      • 5.2.1.2. Non-GMP Grade
  • 5.3. Europe Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Oncology Research
      • 5.3.1.2. Hematology Research
      • 5.3.1.3. Wound Healing Research
      • 5.3.1.4. Dermatology Research
      • 5.3.1.5. Cardiovascular Disease & Diabetes
      • 5.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 5.3.1.7. Others
  • 5.4. Europe Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Pharmaceutical and Biotechnology Companies
      • 5.4.1.2. Research Centers & Academic Institutes
      • 5.4.1.3. CMO and CDMO
  • 5.5. Europe Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.2. Germany Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.3. Germany Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.4. Germany Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.5. U.K. Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.6. U.K. Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.7. U.K. Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.8. U.K. Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.9. France Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.10. France Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.11. France Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.12. France Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.13. Italy Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.14. Italy Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.15. Italy Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.16. Italy Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.17. Turkey Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.18. Turkey Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.19. Turkey Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.20. Turkey Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.21. Russia Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.22. Russia Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.23. Russia Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.24. Russia Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.25. Rest of Europe Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.26. Rest of Europe Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.27. Rest of Europe Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 5.5.1.28. Rest of Europe Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Transforming Growth Factor Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Activin
      • 6.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 6.1.1.3. TGF-beta Proteins
  • 6.2. Asia Pacific Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. GMP Grade
      • 6.2.1.2. Non-GMP Grade
  • 6.3. Asia Pacific Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Oncology Research
      • 6.3.1.2. Hematology Research
      • 6.3.1.3. Wound Healing Research
      • 6.3.1.4. Dermatology Research
      • 6.3.1.5. Cardiovascular Disease & Diabetes
      • 6.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 6.3.1.7. Others
  • 6.4. Asia Pacific Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Pharmaceutical and Biotechnology Companies
      • 6.4.1.2. Research Centers & Academic Institutes
      • 6.4.1.3. CMO and CDMO
  • 6.5. Asia Pacific Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.2. China Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.3. China Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.4. China Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.5. Japan Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.6. Japan Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.7. Japan Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.8. Japan Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.9. South Korea Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.10. South Korea Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.11. South Korea Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.12. South Korea Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.13. India Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.14. India Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.15. India Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.16. India Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.17. Southeast Asia Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.18. Southeast Asia Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.19. Southeast Asia Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.20. Southeast Asia Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Transforming Growth Factor Market Outlook, 2018 - 2031

  • 7.1. Latin America Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Activin
      • 7.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 7.1.1.3. TGF-beta Proteins
  • 7.2. Latin America Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.2.1.1. GMP Grade
      • 7.2.1.2. Non-GMP Grade
  • 7.3. Latin America Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Oncology Research
      • 7.3.1.2. Hematology Research
      • 7.3.1.3. Wound Healing Research
      • 7.3.1.4. Dermatology Research
      • 7.3.1.5. Cardiovascular Disease & Diabetes
      • 7.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 7.3.1.7. Others
  • 7.4. Latin America Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Pharmaceutical and Biotechnology Companies
      • 7.4.1.2. Research Centers & Academic Institutes
      • 7.4.1.3. CMO and CDMO
  • 7.5. Latin America Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.2. Brazil Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.3. Brazil Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.4. Brazil Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.5. Mexico Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.6. Mexico Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.7. Mexico Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.8. Mexico Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.9. Argentina Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.10. Argentina Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.11. Argentina Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.12. Argentina Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Transforming Growth Factor Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Transforming Growth Factor Market Outlook, by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Activin
      • 8.1.1.2. Bone Morphogenetic Proteins (BMPs)
      • 8.1.1.3. TGF-beta Proteins
  • 8.2. Middle East & Africa Transforming Growth Factor Market Outlook, by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. GMP Grade
      • 8.2.1.2. Non-GMP Grade
  • 8.3. Middle East & Africa Transforming Growth Factor Market Outlook, by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Oncology Research
      • 8.3.1.2. Hematology Research
      • 8.3.1.3. Wound Healing Research
      • 8.3.1.4. Dermatology Research
      • 8.3.1.5. Cardiovascular Disease & Diabetes
      • 8.3.1.6. Cell Therapy and Ex vivo Manufacturing
      • 8.3.1.7. Others
  • 8.4. Middle East & Africa Transforming Growth Factor Market Outlook, by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Pharmaceutical and Biotechnology Companies
      • 8.4.1.2. Research Centers & Academic Institutes
      • 8.4.1.3. CMO and CDMO
  • 8.5. Middle East & Africa Transforming Growth Factor Market Outlook, by Country, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.2. GCC Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.3. GCC Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.4. GCC Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.5. South Africa Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.6. South Africa Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.7. South Africa Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.8. South Africa Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.9. Egypt Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.10. Egypt Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.11. Egypt Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.12. Egypt Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.13. Nigeria Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.14. Nigeria Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.15. Nigeria Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.16. Nigeria Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Transforming Growth Factor Market by Product, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Transforming Growth Factor Market by Grade, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Transforming Growth Factor Market by Application, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Transforming Growth Factor Market by End User, Value (US$ Mn) and Volume (Million Units), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. by Application vs by Grade Heatmap
  • 9.2. Manufacturer vs by Grade Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Thermo Fisher Scientific
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Lonza Group AG
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Merck KGaA
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. F. Hoffmann-La Roche Ltd
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Abcam plc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Bio-Techne.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Sartorius CellGenix GmbH
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Proteintech Group, Inc.
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. PeproTech Inc.
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Cell Signaling Technology, Inc.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Meridian Bioscience Inc.
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Applied Biological Materials (abm), Inc.
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Akron Biotech
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Leadgene Biomedical, Inc
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. GE Healthcare
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations